Unveiling the Etiological Impact of Gst-M1, Gst-T1, and P53 Genotypic Variations on Brain Carcinogenesis

dc.contributor.author Dirican, Onur
dc.contributor.author Kaygin, Pinar
dc.contributor.author Oguztuzun, Serpil
dc.contributor.author Husseini, Abbas Ali
dc.contributor.author Sarialtin, Sezen Yilmaz
dc.contributor.author Yilmaz, Can
dc.contributor.author Izci, Yusuf
dc.date.accessioned 2025-05-10T17:24:15Z
dc.date.available 2025-05-10T17:24:15Z
dc.date.issued 2024
dc.description Dirican, Onur/0000-0003-0511-6611; Unlu, Nihan/0000-0001-5772-2838 en_US
dc.description.abstract Background Functional variants of glutathione-S-transferase (GST)-M1, GST-T1, p53 might modulate brain cancer risk by altering the rate of metabolism and clearance of carcinogens from the brain tissue. In this study, the role of GST-M1, GST-T1, p53 polymorphisms on brain tumor was investigated.Methods and results Brain tumor tissues of 143 patients were obtained from the Gulhane Training and Research Hospital, Department of Neurosurgery between 2019 and 2020. In the xenobiotic mechanism, the null allele frequency in the GST-T1, GST-M1 gene regions of Phase II enzymes by qPCR method were investigated. Single nucleotide polymorphism encoding Arg/Pro conversion in the p53 gene region was analyzed in 120 cases by sequence analysis method. The data were analyzed statistically with patient's demographic and clinical data. GST-M1, GST-T1, p53 genotypes of the patient group were determined. The most frequent genotype was null genotype (0/0) for GST-M1 (chi(2) = 39.756, p < 0.001). GST-M1 genotype frequencies were 30.8%, 23.1%, 44.3% for 1/1, 1/0, 0/0, respectively. The most frequent genotype was GST-T1 1/1 following by GST-T1 1/0 (chi(2) = 0.335, p = 0.846). GST-T1 genotype frequencies were 64.3%, 30.8%, 4.9% for 1/1, 1/0, 0/0, respectively. GST-M1 null genotype might be associated with the development of brain tumors. Genotype distribution obtained in p53 exon 4 codon 72; Arg/Arg was determined as 31 (25.8%), Arg/Pro 70 (58.3%), and Pro/Pro 19 (15.8%) in the case group, while there were 18 (38.3%), 23 (48.9%), and 6 (12.8%) respectively in the control group. However, the genotype distribution of p53 exon 4 codon 72 among tumorous tissue did not significantly vary from healthy control tissues (chi(2)=2.536, p = 0.281).Conclusion The null allele frequency encountered in the GST-M1, GST-T1 gene regions is consistent with the rates in the gene pool called Caucasian in the literature. GST-M1 gene polymorphism may play a crucial role in brain carcinogenesis in Turkish patients. This study based on clinical data is thought to help to understand the important epidemiological features of brain tumors. en_US
dc.identifier.doi 10.1007/s11033-023-08985-2
dc.identifier.issn 0301-4851
dc.identifier.issn 1573-4978
dc.identifier.scopus 2-s2.0-85181224591
dc.identifier.uri https://doi.org/10.1007/s11033-023-08985-2
dc.identifier.uri https://hdl.handle.net/20.500.14720/11140
dc.language.iso en en_US
dc.publisher Springer en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Brain Tumors en_US
dc.subject Gst-T1 en_US
dc.subject Gst-M1 en_US
dc.subject P53 en_US
dc.subject Polymorphism en_US
dc.title Unveiling the Etiological Impact of Gst-M1, Gst-T1, and P53 Genotypic Variations on Brain Carcinogenesis en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Dirican, Onur/0000-0003-0511-6611
gdc.author.id Unlu, Nihan/0000-0001-5772-2838
gdc.author.scopusid 57194340152
gdc.author.scopusid 57201527456
gdc.author.scopusid 26644418800
gdc.author.scopusid 56194505100
gdc.author.scopusid 57146469600
gdc.author.scopusid 57221517895
gdc.author.scopusid 57212446182
gdc.author.wosid Yilmaz, Sezen/A-4724-2017
gdc.author.wosid Husseini, Abbas/Aaf-9955-2019
gdc.author.wosid Unlu, Nihan/Jfj-5523-2023
gdc.author.wosid Yilmaz, Can/Grs-2754-2022
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Dirican, Onur] Istanbul Gelisim Univ, Vocat Sch Hlth Serv, Dept Pathol Lab Tech, Istanbul, Turkiye; [Kaygin, Pinar; Oguztuzun, Serpil] Gaziantep Univ, Fac Art & Sci, Dept Biol, Gaziantep, Turkiye; [Husseini, Abbas Ali] Istanbul Gelisim Univ, Life Sci & Biomed Engn Applicat & Res Ctr, Istanbul, Turkiye; [Sarialtin, Sezen Yilmaz] Ankara Univ, Fac Pharm, Dept Pharmaceut Toxicol, Ankara, Turkiye; [Yilmaz, Can] Univ Yuzuncu Yıl, Fac Art & Sci, Dept Mol Biol & Genet, Van, Turkiye; [Unlu, Nihan] Istanbul Gelisim Univ, Vocat Sch Hlth Sci, Dept Med Serv & Tech, Istanbul, Turkiye; [Izci, Yusuf] Univ Hlth Sci, Gulhane Training & Res Hosp, Dept Neurosurg, Ankara, Turkiye en_US
gdc.description.issue 1 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q3
gdc.description.volume 51 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q3
gdc.identifier.pmid 38158432
gdc.identifier.wos WOS:001132269100003
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files